The company said Friday the vaccine was 66% effective overall at preventing moderate to severe illness.
Johnson & Johnson is appealing the decision, which could be the first of many legal battles.
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
Big jury verdicts have made Missouri a target for tort reform.